BNP PARIBAS FINANCIAL MARKETS - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 133 filers reported holding CYTOKINETICS INC in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$3,028,635
+65.9%
102,805
+83.7%
0.00%
+100.0%
Q2 2023$1,825,056
-35.0%
55,949
-29.8%
0.00%
-50.0%
Q1 2023$2,805,628
+14.1%
79,728
+48.6%
0.00%0.0%
Q4 2022$2,459,159
-100.0%
53,670
-48.5%
0.00%
-50.0%
Q3 2022$5,048,684,000
+111.4%
104,204
+71.4%
0.01%
+100.0%
Q2 2022$2,388,478,000
-8.7%
60,791
-14.5%
0.00%0.0%
Q1 2022$2,616,639,000
-69.9%
71,085
-62.7%
0.00%
-66.7%
Q4 2021$8,693,929,000
+179.4%
190,740
+119.1%
0.01%
+200.0%
Q3 2021$3,111,346,000
+367.0%
87,055
+158.6%
0.00%
+300.0%
Q2 2021$666,250,000
+43.2%
33,666
+68.3%
0.00%0.0%
Q1 2021$465,363,000
+135.3%
20,007
+110.2%
0.00%
Q4 2020$197,805,000
-45.8%
9,519
-43.5%
0.00%
-100.0%
Q3 2020$364,673,000
+140.5%
16,844
+161.8%
0.00%
Q2 2020$151,649,000
-93.8%
6,434
-96.9%
0.00%
-100.0%
Q1 2020$2,460,408,000
+1704.8%
208,686
+1524.1%
0.01%
Q4 2019$136,328,000
+54.4%
12,849
+65.6%
0.00%
Q3 2019$88,275,000
+53.6%
7,757
+51.9%
0.00%
Q2 2019$57,454,000
-25.8%
5,107
-46.6%
0.00%
Q1 2019$77,429,000
+76562.4%
9,571
+59718.8%
0.00%
Q4 2018$101,000
-99.3%
16
-99.0%
0.00%
Q3 2018$15,130,000
+18.7%
1,5360.0%0.00%
Q2 2018$12,749,000
-87.9%
1,536
-89.5%
0.00%
Q1 2018$105,019,000
-33.3%
14,586
-24.5%
0.00%
Q4 2017$157,401,000
-56.3%
19,313
-22.2%
0.00%
-100.0%
Q3 2017$359,818,000
+123.1%
24,815
+86.2%
0.00%
Q2 2017$161,269,000
+4198.2%
13,328
+4464.4%
0.00%
Q1 2017$3,752,000
-83.8%
292
-84.7%
0.00%
Q4 2016$23,146,000
+10.5%
1,905
-16.5%
0.00%
Q3 2016$20,940,000
+67.5%
2,281
+73.2%
0.00%
Q2 2016$12,498,000
-82.2%
1,317
-80.3%
0.00%
Q4 2015$70,040,000
+24.8%
6,696
-20.2%
0.00%
Q3 2015$56,129,000
+189.4%
8,390
+190.7%
0.00%
Q2 2015$19,394,000
+248.8%
2,886
+252.0%
0.00%
Q1 2015$5,560,000
-25.3%
820
-61.2%
0.00%
Q3 2014$7,448,000
+2097.1%
2,116
+2880.3%
0.00%
Q2 2014$339,000
+294.2%
71
+273.7%
0.00%
Q1 2014$86,000
-96.2%
19
-94.5%
0.00%
Q4 2013$2,243,0003450.00%
Other shareholders
CYTOKINETICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,723,170$13,940,0005.01%
RP Management, LLC 875,656$7,084,0003.54%
BVF INC/IL 3,801,817$30,757,0003.44%
DAFNA Capital Management LLC 400,294$3,238,0001.40%
Virtus ETF Advisers LLC 33,758$273,0000.58%
IRONWOOD INVESTMENT MANAGEMENT LLC 67,352$545,0000.44%
WASATCH ADVISORS LP 3,188,487$25,795,0000.28%
LANSDOWNE PARTNERS (UK) LLP 1,459,706$11,809,0000.26%
Campbell & CO Investment Adviser LLC 43,844$355,0000.18%
Fosun International Ltd 239,792$1,981,0000.13%
View complete list of CYTOKINETICS INC shareholders